David Eichenbaum, MD
Curriculum Vitae

 

David Aaron Eichenbaum, MD


Retina Vitreous Associates of Florida

4344 Central Avenue
St. Petersburg, Florida 33711
Phone (727) 323-0077
Fax (727) 323-7627

579 South Duncan Avenue
Clearwater, Florida 33756
Phone (727) 445-9110
Fax (727) 466-0306

Employment

Retina Vitreous Associates of Florida – St. Petersburg, Clearwater, and Tampa, Florida
July 2007-2018     

Academic Appointments

Clinical Assistant Professor, Department of Ophthalmology
November 2007-2018, University of South Florida College of Medicine – Tampa, Florida

 

Fellowship

Vitreoretinal Surgery, Tufts/Ophthalmic Consultants of Boston
July 2005 - June 2007

 

Residency

University of South Florida College of Medicine
July 2002 - June 2005

Austin Medical Education Program – Transitional Internship
July 2001 - June 2002

 

Education



University of South Florida College of Medicine
August 1997 - May 2001


University of South Florida College of Arts and Sciences
August 1994 – July 1997

Clinical Trials

Monthly Ranibizumab versus Treat and Extend Ranibizumab for Diabetic Macular Edema, Principal Investigator, 2012-Present.


Topical lidocaine gel with and without subconjunctival lidocaine injection for intravitreal injection, Sub-Investigator, 2012-2013.


The University of Virginia TOGA-01: Treatment with Oracea for Geographic Atrophy: Phase 2/3 Study Evaluating the Safety and Efficacy of daily oral administration of doxycycline (ORACEA) vs placebo in subjects with GA, Site Principal Investigator, 2014-Present.


Ophthotech Protocol OPH1004A SOLARIS: A Phase 3 Randomized, Double-Masked, Controlled Trial to Establish the Safety and Efficacy of Intravitreous Administration of Fovista (Anti PDGF-B Pegylated Aptamer) Administered in Combination with Either Avastin or Eylea Monotherapy in Subjects with Neovascular Age-Related Macular Degeneration, Site Principal Investigator, 2014-Present.


Thrombogenics Protocol TG-MV-018 ORBIT: Ocriplasmin Research to Better Inform Treatment A Phase 4 Trial Evaluating the Clinical Outcomes and Safety in Patients Receiving Jetrera for the Treatment of Symptomatic Vitreomacular Adhesion, Site Principal Investigator, 2014-Present.

Thrombogenics Protocol TG-MV-022 OZONE: A Retropective Review of Patients Treated with Ocriplasmin for Symptomatic VMA Retrospective Observational Trial, Site Principal Investigator, 2014 - Present.

Genentech/Roche Protocol GX29185 SPECTRI: A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration, Site Principal Investigator, 2014-Present.

Allergan Protocol 190342-038 BEACON: A Phase 2 Study Assessing the Safety and Efficacy of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-Related Macular Degeneration, Site Principal Investigator, 2015-Present.

Allergan Protocol 150998-005 CEDAR: A Phase 3 Study Assessing the Safety and Efficacy of Abicipar Pegol in Patients with Age-Related Macular Degeneration, Site Principal Investigator, 2015-Present.

Alcon Protocol RTH-258-C001 HAWK: A Double-Masked, Multicenter, Three-Arm Phase 3 Study Comparing the Efficacy of RTH-258 Versus Aflibercept in Subjects with Neovascular Age-Related Macular Degeneration, 2015-Present.

Genentech/Roche Protocol GX29176 CHROMA: A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration, Site Principal Investigator, 2016-Present.

Genentech/Roche Protocol BP29647 AVENUE: A Proof-of-Concept Study of RG7716 in Participants with Choroidal Neovascularization Secondary to Age-Related Macular Degeneration, Site Principal Investigator, 2016-Present.

Genentech/Roche Protocol BP30099 BOULEVARD: A Phase 2 Study of RO6867461 in Participants with Center-Involving Diabetic Macular Edema, Site Principal Investigator, 2016-Present.

Allergan Protocol 150998-006 SEQUOIA: A Phase 3 Study Assessing the Safety and Efficacy of Abicipar Pegol in Patients with Age-Related Macular Degeneration, Site Sub-Investigator, 2016-Present.


 

Honors

Awards


Appointed Offices


Residency


College of Medicine

 

 

Certification

American Board of Ophthalmology, Certified 2007
Florida Medical License: ME90466

 

Hospital Privileges

St. Anthony’s Hospital, St. Petersburg, Florida
Physicians Surgery Center at St. Anthony’s Hospital, St. Petersburg, Florida
All Children’s Hospital, St. Petersburg, Florida
Largo Medical Center, Indian Rocks Campus, Largo, Florida
St. Joseph’s Hospital, Tampa, Florida
Tampa General Hospital, Tampa, Florida

 

Research Interests and Publications

 

Articles

Jaffrey C , Eichenbaum D, Denham D, Norman J.  A Novel Pancreatic Model: the Snip Method of Pancreatic Isolation for In Vitro Study.  Pancreas, 1999; 19:377-381.

Goldstein B, Eichenbaum D. A 65 Year-Old Woman with Visual Changes.  Digital Journal of Ophthalmology, 2005. Accessed  15 March  2007. <http://www.djo.harvard.edu/site.php?url=/physicians/gr/799>

Eichenbaum D, Pavan P. Maculopathy in a Young Person. Digital Journal of Ophthalmology, 2006. Accessed 15 March 2007.  <http://www.djo.harvard.edu/site.php?url=/physicians/gr/875>

Baumal C, Eichenbaum D. Intravitreal Bevacizumab for the Treatment of Subfoveal CNV Secondary to AMD. Retina Today, Summer 2006; 16-18.

Eichenbaum D, Heier J. Multiple Repeated Intravitreal Triamcinolone Treatment for Radiation-Induced Macular Edema. Retinal Cases and Brief Reports, Fall 2007; 1(4):202-204.

Eichenbaum D. The Job Search and Interviewing. Retina Today. January/February 2008; 24-25.

Eichenbaum D. Navigating Contract Negotiating. Retina Today. March/April 2008; 20-21.

Slonim CB, Raizman MD, Eichenbaum DA, Nichols-Kay C, Joshi S, Gallager P. Uveitis. Ocular Infection and Inflammation, Winter 2009; 1(2): 3-13

Davis A, Cohen SM Pautler SE, Billiris-Findlay K, Eichenbaum DA.  Acta Ophthalmologica. Beta Blocker Use and Age-Related Macular Degeneration.  March 2012; 90(2): 232-233.

Golen JR, Eichenbaum DA.  Retinal Cases and Brief Reports.  Neovascularization of the Optic Disk and Vitreous Hemorrhage After Immune Recovery and Treatment of Cytomegalovirus Retinitis in an HIV-Positive Patient.  Fall 2013; 7(4): 395-298.

Eichenbaum DA, Wolfe JD, Law JC, Shah RJ. Retina Times. Road-Testing the Alcon Ultravit High Speed Vitrectomy Probe.  Winter 2013; 31(5): 29-31.


Cohen S, Billiris-Findlay K, Eichebaum D, Pautler S.  Ophthalmic Surgery, Lasers, and Imaging Retina. Topical Lidocaine Gel With and Without Subconjunctival Lidocaine Injection for Intravitreal Injection: a Within-Patient Study. June 2014. 45(4):306-10.


Eichenbaum DA. Retina Today.  Exploring the DME Treatment Decision Tree.  November/December 2014; 52-58.


Patel HS, Eichenbaum DA. Ophthalmic Surgery, Lasers, & Imaging Retina. Geographic Atrophy: clinical impact and emerging treatments.  January 2015; 46(1): 8-13.


Eichenbaum DA, Kitchens JW, Moshfeghi AA. Retina Today.  Switching Therapies in Patients with DME.  April 2015; 10(3) 74-76.


Patel HS, Eichenbaum DA. Retina Today.  Breakthrough Treatment Modalities for Hereditary Retinal Diseases. April 2016; 1-3.


Eichenbaum, DA.  Millenial Eye.  Lighting in a Bottle: and exploration of the rapid pace of innovation in medical and surgical retina.  Cover Focus, May/June 2016.


Supplements, Roundtables, and Panels


Boyer DS, Gonzalez VH, Eichenbaum DA. Retina Today. DRCR.net Protocol T: A comparative effectiveness of intravitreal aflibercept, bevacizumab, and ranibizumab for diabetic macular edema. March 2014.


Eichenbaum D, Albini T, Fortun JA, Kitchens JW, Reichel E.  Retina Today.  Current Insights Into the Management of Diabetic Macular Edema.  April 2014.


Pieramici D, Blaha G, Eichenbaum D, Singh R.  Supplement to Retina Today.  An Update on the Latest Clinical Trials on DME: Are They Applicable to Other Disease States? November/December 2015


 

 

Abstracts

Groden L, Dorsett K., Eichenbaum D.  Pachymetry Studies in LASIK.  Abstract, 2000. Castroviejo Cornea Society, 26th Annual Meeting, October 21, 2000.

 

Book Chapters

Eichenbaum DA, Slonim CB.  Disorders of the eye.  Cuppett M, Walsh KM, eds. General Medical Conditions in the Athlete.  St. Louis: Mosby Inc; 2005: 217-242.

Henderson BA, Steinert RF, Eichenbaum DA, Heier JS. Complications of IOL Surgery.  In: Albert D, Miller J, Azar D, Blodi B, eds. Albert & Jakobiec’s Principles & Practice of Ophthalmology. Amsterdam: Elsevier; 2007: Sect 9 Ch 121 pg 1-37.

Eichenbaum D, Reichel E. Optical Coherence Tomography in the Evaluation and Management of Age-Related Macular Degeneration. In: Age-Related Macular Degeneration, Second Edition. Italy: Informa Healthcare; 2007: 177-185.

Eichenbaum DA, Park RI, Topping TM.  Postoperative Endophthalmitis.  In: Steinert R, ed.  Cataract Surgery. Amsterdam: Elsevier; 2009: Part VII Ch 55 pg 671-679.

Small L, Eichenbaum DA, Slonim CB.  Disorders of the Eye. Cuppett M and Walsh KM, eds. Medical Conditions in the Athlete (2nd edition).  St. Louis: Elsevier Mosby; 2012

 

Posters

Eichenbaum D, Groden L. “Lasik Surgery Noncandidates.” Poster. San Diego: American Society of Cataract and Refractive Surgeons, 2004.

Eichenbaum D, Rogers A, Reichel E, Baumal C, Duker J. “Intraocular Bevacizumab (Avastin) for the Treatment for Choroidal Neovascularization and Retinal Vasculopathies.”  Poster.  Ft. Lauderdale: Association for Vision and Research in Ophthalmology, 2006.

Eichenbaum D, Nguyen J, Heier J. “Ranibizumab in Patients With Choroidal Neovascularization Secondary to Causes Other Than Age-Related Macular Degeneration: A Phase I Study.”  Poster.  Ft. Lauderdale: Association for Vision and Research in Ophthalmology, 2007.

Nguyen J, Eichenbaum D, Heier J. “Ranibizumab Treatment of Patients With Neovascular AMD Previously Treated With Intravitreal Bevacizumab.” Poster. Ft. Lauderdale: Association for Research in Vision and Ophthalmology, 2007.

Wiegand T, Rogers A, Yates P, Eichenbaum D, Reichel E, Duker J. “Intravitreal Injection of Bevacizumab (Avastin) for Choroidal Neovascularization Caused by Angioid Streaks.”  Poster.  Ft. Lauderdale: Association for Research in Vision and Ophthalmology, 2007.

Eichenbaum D, Cohen S, Pautler S, Billiris-Findlay K. “A Prospective Study of Ranibizumab for DME: Monthly injections vs Treat-and-Extend.”  Poster.  Toronto: American Society of Retinal Specialists, 2013.

Eichenbaum D, Cohen S, Billiris-Findlay, K.  “Monthly Versus Treat-and-Extend Ranibizumab for Center-Involving Diabetic Macular Edema: a Prospective Randomized Investigator-Sponsored Trial,” American Society of Retinal Specialists, August 11, 2014.

Pautler SE, Cohen SM, Findlay KB, Eichenbaum DA, Lopez M. Clinical findings of the posterior uveal effusion syndrome. American Academy of Ophthalmology. 2015 Annual Meeting. Abstract ID 30043320. Poster Presentation PO476

Miscellaneous

Eichenbaum D, Goldstein B. Development of a novel intraocular foreign body basket, and design of prototype instruments. 2003-2005.

Eichenbaum D. Idiopathic Polypoidal Choroidal Vasculopatthy (IPCV). Open Courseware. New England Eye Center, Tufts University School of Medicine, 2007. Accessed 7 August 2012. http://ocw.tufts.edu/data/37/496646.pdf

 

Professional Associations

American Academy of Ophthalmology
Association of Research in Vision and Ophthalmology
American Society of Retina Specialists
American Medical Association
Vit-Buckle Society
Florida Society of Ophthalmology
Tampa Bay Ophthalmic Society

 

Presentations

“New Treatments for Macular Degeneration” Grand Rounds, Palms of Pasadena Hospital, St. Petersburg, Florida August 9, 2007

“Treating Neovascular Age-Related Macular Degeneration: 2007 and Beyond” Resident Lecture, University of South Florida College of Medicine, Tampa, Florida August 30, 2007

“Treatment Advances in Macular Degeneration” Grand Rounds, Suncoast Hospital, Largo, Florida September 13, 2007

“Macular Degeneration Update” University of South Florida/All Children’s Hospital Retina Update Course, St. Petersburg, Florida, February 1, 2008

“The Neonatal Eye Exam and Retinopathy of Prematurity” Nursing Seminar All Children’s Hospital, St. Petersburg, Florida, June 30, 2008

“Photodynamic Therapy in 2009” Resident Lecture, University of South Florida College of Medicine, Tampa, October 16 2008

"Diabetic Retinopathy: 2009 and Beyond" University of South Florida/All Children’s Hospital Retina Update Course, St. Petersburg, Florida, February 6, 2009

"Retinal Detachment Surgery" Grand Rounds, Palms of Pasadena Hospital, St. Petersburg, Florida, August 20, 2009

"Navigate" Ophthalmic Technician Education, sponsored by Genentech, Renaissance Charlotte South Park Hotel, Charlotte, North Carolina, September 10, 2009

"Navigate" Ophthalmic Technician Education, sponsored by Genentech, Westin Hotel, Richmond, Virgina, October 13, 2009

"Navigate" Ophthalmic Technician Education, sponsored by Genentech, Marriott Country Club Plaza, Kansas City, Missouri, November 10, 2009

"Clinical AMD - Pearls for the Technician" Joint Commission on Allied Health Professionals in Ophthalmology, Continuing Education Webinar, November 17, 2009

"Imaging for AMD - Pearls for the Technician" Joint Commission on Allied Health Professionals in Ophthalmology, Continuing Education Webinar, January 12, 2010

"Retina Techtrax" Continuing Education Program, Joint Commission on Allied Health Professionals in Ophthalmology and American Society of Ophthalmic Registered Nurses, Doubletree Resort, Orlando, Florida, January 16, 2010

"Retinal Vein Occlusion: Is There Less Frustration Now?" University of South Florida/All Children’s Hospital Retina Update Course, St. Petersburg, Florida, February 5, 2010

"Implantable Drug Delivery Devices" University of South Florida College of Medicine, Tampa, Florida, March 15, 2010

“Retinopathy of Prematurity 2010” Nursing Seminar All Children’s Hospital, St. Petersburg, Florida, April 29, 2010

"Implantable Drug Delivery Systems" Pinellas County Optometric Society, Largo, Florida, May 11, 2010

"Navigate" Ophthalmic Technician Education, sponsored by Genentech, Marriott Raleigh Crabtree Valley Hotel, Raleigh, North Carolina, October 21, 2010

"Navigate" Ophthalmic Technician Education, sponsored by Genentech, Griffin Gate Marriott Hotel, Lexington, Kentucky, October 26, 2010

"Navigate" Ophthalmic Technician Education, sponsored by Genentech, Hutton Hotel, Nasville, Tennessee, November 11, 2010

"Navigate" Ophthalmic Technician Education, sponsored by Genentech, Boca Raton Marriott at Boca Center, Boca Raton, Florida, November 18, 2010

“Advances in Vitrectomy” University of South Florida/All Children’s Hospital Retina Update Course, St. Petersburg, Florida, February 4, 2011

GENIE Peer Education Program, sponsored by Genentech, Chart House, Wilmington, North Carolina, March 24, 2011

“Hereditary Retinal Dystrohies” University of South Florida Eye Institute, Tampa, Florida, June 16, 2011

GENIE Peer Education Program, sponsored by Genentech, Courtine’s Restaurant, Stuart, Florida, June 30, 2011

GENIE Peer Education Program, sponsored by Genentech, Global Grill, Pensacola, Florida, September 8, 2011

GENIE Peer Education Program, sponsored by Genentech, River Oaks Restaurant, Memphis, Tennessee, September 13, 2011

Diabetes Support Group Question and Answer Session, St. Anthony’s Hospital, St. Petersburg, Florida, September 14, 2011

“Retinopathy of Prematurity Update: ‘Intravitreal Bevacizumab or Laser?’,” University of South Florida College of Medicine, Tampa, Florida, September 21, 2011

GENIE Peer Education Program, sponsored by Genentech, Brass Lantern Restaurant, Dunn, North Carolina, October 26, 2011

GENIE Peer Education Program, sponsored by Genentech, Cobalt, Vero Beach, Florida, November 17, 2011

GENIE Peer Education Program, sponsored by Genentech, Cobalt, Vero Beach, Florida, January 19, 2012

GENIE Peer Education Program, sponsored by Genentech, Delmonico, New Orleans, Louisiana, January 26, 2012

GENIE Peer Education Program, sponsored by Genentech, Carlo’s, Roanoke, Virginia, February 23, 2012

GENIE Peer Education Program, sponsored by Genentech, Top Thai, Dothan, Alabama, March 15, 2012

“New Options in Age-Related Macular Degeneration,” Academy of Senior Professionals at Eckerd College, St. Petersburg, Florida, March 24, 2012

“New Ideas for Diabetic Macular Edema” University of South Florida/All Children’s Hospital Retina Update Course, St. Petersburg, Florida, April 6, 2012

GENIE Peer Education Program, sponsored by Genentech, Mark’s Prime Steakhouse, Gainesville, Florida, May 3, 2012

GENIE Peer Education Program, sponsored by Genentech, Biaggi’s Ristorante Italiano, Evansville, Indiana, July 19, 2012

GENIE Peer Education Program, sponsored by Genentech, Tarpy’s Roadhouse, Monterey, California, August 15, 2012

GENIE Peer Education Program, sponsored by Genentech, The Chelsea, New Bern, North Carolina, September 6, 2012

GENIE Peer Education Program, sponsored by Genentech, River Oaks Restaurant, Memphis, Tennessee, October 4, 2012

GENIE Peer Education Program, sponsored by Genentech, Firefly, Panama City Beach, Florida, October 25, 2012

GENIE Peer Education Program, sponsored by Genentech, Alexander’s, Roanoke, Virginia, November 13, 2012

“Ocriplasmin for the Treatment of Symptomatic Vitreomacular Adhesion: a Review of the MIVI-TRUST Program” University of South Florida/All Children’s Hospital Retina Update Course, St. Petersburg, Florida, February 1, 2013

“Is it Time to Follow or Refer?” Pinellas County Optometric Association, Cafe Ponte, Clearwater, Florida February 12, 2013

GENIE Peer Education Program, sponsored by Genentech, Arthur’s Prime, Little Rock, Arkansas, February 26, 2013

GENIE Peer Education Program, sponsored by Genentech, Ruth’s Chris, St. Louis, Missouri, March 7, 2013

GENIE Peer Education Program, sponsored by Genentech, Ruth’s Chris, Memphis, Tennessee, April 4, 2013

“DME in 2013: Which Bullett and How Many Shots?” Vit-Buckle Society Meeting, Fantainbleau Hotel, Miami, Florida April 12, 2013

GENIE Peer Education Program, sponsored by Genentech, Anson’s, Charleston, South Carolina, April 30, 2013

“DME in 2013: Which Bullett and How Many Shots?” University of South Florida Eye Institute, Tampa, Florida April 12, 2013

GENIE Peer Education Program, sponsored by Genentech, Ruth’s Chris, Memphis, Tennessee, June 5, 2013

“The Neonatal Eye Exam and Retinopathy of Prematurity” Nursing Seminar All Children’s Hospital, St. Petersburg, Florida, July 17, 2013

 

Clinical Advisory Boards and Workshops

Macugen Clinical Advisory Board, sponsored by Eyetech, Marriott Biscayne Bay, Miami, Florida, February 17-18, 2012

Key Opinion Leader Workshop at Diabetic Macular Edema Launch, sponsored by Genentech,Omni San Diego, San Diego, California, August 7, 2012

National Retinal Sales Meeting Training Seminar, sponsored by Allergan, Loews Royal Pacific Hotel, Orlando, Florida, January 31, 2013

Lucentis National Advisory Board Meeting, Clinical Expert in Diabetic Macular Edema, sponsored by Genetech, Platinum Hotel, Las Vegas, Nevada, June 8, 2013

 

Community Service

Radio Reading Service for the Vision Impaired  –  WUSF 89.7 FM Tampa, Florida 2003-2005

Community Seminar – “Macular Degeneration: Newest Information on Research and Treatment,” Macula Vision Research Foundation, Chestnut Hill, Massachusetts, June 10, 2006

Community Seminar – “Macular Degeneration: Answering Your Questions,” The Fountains at Boca Ciega Bay, St. Petersburg, Florida, November 28, 2007

Community Seminar – “Macular Surgery: Answering Your Questions,” The Fountains at Boca CIega Bay, St. Petersburg, Florida, January 17, 2008

Community Seminar – “Lunch and Learn: Macular Degeneration,”  Gulfport Senior Center, Gulfport, Florida, January 22, 2008

Community Seminar – “Macular Degeneration Advancements,” St. Anthony’s Hospital Auxiliary, St. Petersburg, Florida, March 26, 2008

Community Seminar – “Question and Answer: Your Aging Eyes,” Friendship Club at Town Shores, Gulfport, Florida, May 6, 2008

Community Seminar – “Question and Answer: Macular Degeneration,” Benjamin Tower, St. Petersburg, Florida, May 22, 2008

“2008 Eye on AMD Program,” sponsored by Genentech, Renaissance Charlotte South Park Hotel, Charlotte, North Carolina, July 8, 2008

“2008 Eye on AMD Program,” sponsored by Genentech, Embassy Suites Birmingham, Birmingham, Alabama, July 12, 2008

“2008 Eye on AMD Program,” sponsored by Genentech, Jacksonville Marriott, Jacksonville, Florida, November 1, 2008

"Foundation for Fighting Blindness Tampa Vision Seminar," A la Carte Pavilion, Tampa, Florida, February 21, 2009

"2009 Eye on AMD Program," sponsored by Genentech, Renaissance Charlotte South Park Hotel, Charlotte, North Carolina, March 12, 2009

Community Seminar - "Question and Answer: Macular Degeneration" Westminster Suncoast, St. Petersburg, Florida, April 30, 2009

"2009 Eye on AMD Program" sponsored by Genentech, Philadelphia, Pennsylvania, June 6, 2009

Community Seminar - "Macular Degeneration and Macular Surgery" St. Anthony's Physician Surgery Center, St. Petersburg, Florida, April 24th, 2010

Community Seminar - "Insight to Your Eyesight" Magnolia Gardens, Pinellas Park, Florida, April 27, 2010

Community Seminar - “Diabetes and Your Eyes” St. Anthony’s Hospital, St. Petersburg, Florida, March 2, 2011

Community Seminar - Diabetes Support Group at St. Anthony’s Hospital, St. Petersburg, Florida, November 14, 2012

Honorary Medical Chair, Foundation Fighting Blindness Vision Walk Tampa Bay 2013